These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 577462)

  • 1. [Experimental study on the tolerance of different oral potassium preparations in rats (author's transl)].
    Renker H; Schaub E; Bürgin M; Zanoletti A; Chovan K; Müller A
    Arzneimittelforschung; 1977; 27(4):845-51. PubMed ID: 577462
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcerogenic properties of enteric coated compounds in dogs.
    Stahlgren LH; Dapena A; Roy RL
    Surg Forum; 1965; 16():367-8. PubMed ID: 5888407
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium therapy and gastrointestinal lesions.
    Emerson DN
    S D J Med; 1970 Apr; 23(4):13-4 passim. PubMed ID: 5269938
    [No Abstract]   [Full Text] [Related]  

  • 4. Reasons for the removal of an enteric-coated slow-release potassium preparation from the market in France.
    Trechot P; Netter P; Moore N; Vidrequin A; Boissel P; Voltz C
    Am J Gastroenterol; 1990 Mar; 85(3):330-1. PubMed ID: 2309690
    [No Abstract]   [Full Text] [Related]  

  • 5. Enteric-coated potassium.
    Med Lett Drugs Ther; 1974 Jan; 16(1):2-3. PubMed ID: 4808612
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenosing ulcers of the small intestine associated with slow release potassium tablets.
    Heffernan SJ; Fogarty O; Murphy JJ
    Ir Med J; 1975 Aug; 68(15):366-8. PubMed ID: 1181332
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE; Paton TW; Cowan DH; Manuel MA; Dranitsaris G
    CMAJ; 1989 Sep; 141(6):543-7. PubMed ID: 2776093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral depot preparations].
    Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Dec; 93(34):2497-8. PubMed ID: 4771159
    [No Abstract]   [Full Text] [Related]  

  • 11. Potassium supplement tablets.
    Winterton W; Manton W
    Med J Aust; 1971 Jan; 1(5):292. PubMed ID: 5545981
    [No Abstract]   [Full Text] [Related]  

  • 12. Side-effects of potassium chloride in products with different dissolution rates.
    Graffner C; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):19-26. PubMed ID: 5575870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Absence of effect of ethanol and apple brandy on the upper digestive tract and esophagus of the Wistar rat. Part of a research project to assess etiological factors of cancer of the esophagus in the west of France (author's transl)].
    Mandard AM; Marnay J; Hélie H; Tuyns AJ; Le Talaer JY
    Bull Cancer; 1981; 68(1):49-58. PubMed ID: 7225607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical efficacy study on the gastrointestinal tolerance of potassium citrate when used as a supplement in diuretic therapy.
    Dawson D
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):3-5. PubMed ID: 4963022
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of three delivery systems of oral potassium on upper gastrointestinal mucosa.
    McLoughlin JC
    Br J Clin Pract; 1987 Aug; 41(8):865-8. PubMed ID: 3449114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potassium-induced ulcers of the small intestine].
    Räf LE
    Lakartidningen; 1968 Jan; 65(5):461-71. PubMed ID: 5723548
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vivo and in vitro studies of the release of active ingredients in solid oral pharmaceutical preparations containing potassium chloride].
    Ekes G; Szentmiklósi P; Rácz I; Mezei J; Küttel S; Jancsó S
    Acta Pharm Hung; 1985 Sep; 55(5):163-7. PubMed ID: 4061085
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement.
    Lowance DC; Murad F; Darrow WR; Bonus L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):204-8. PubMed ID: 7095919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enteral absoprtion of ascorbic acid in man after application of a micro-encapsulated retard preparation (author's transl)].
    Brenner G
    Med Klin; 1975 Jul; 70(28-29):1219-22. PubMed ID: 1177790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who needs slow-release potassium tablets?
    Med Lett Drugs Ther; 1975 Aug; 17(18):73-4. PubMed ID: 1165748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.